We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+10.85%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$37.6B
AUM Growth
+$4.89B
(+15%)
Cap. Flow
+$2.25B
Cap. Flow
% of AUM
5.98%
Top 10 Holdings %
Top 10 Hldgs %
23.7%
Holding
2,051
New
98
Increased
1,226
Reduced
674
Closed
47
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$202M |
| 2 |
Linde
LIN
|
+$201M |
| 3 |
Apple
AAPL
|
+$192M |
| 4 |
NVIDIA
NVDA
|
+$187M |
| 5 |
Fastenal
FAST
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$163M |
| 2 |
IBM
IBM
|
+$38.3M |
| 3 |
Target
TGT
|
+$35M |
| 4 |
Sherwin-Williams
SHW
|
+$33.8M |
| 5 |
S&P Global
SPGI
|
+$32.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.52% |
| 2 | Industrials | 11.95% |
| 3 | Consumer Staples | 11.58% |
| 4 | Consumer Discretionary | 9.61% |
| 5 | Financials | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TWKS
1926
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $42.1K | ﹤0.01% |
16,635
+1,308
| +9% | +$5.02K |
|
|
SHCR
1927
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $41.9K | ﹤0.01% |
54,581
+3,536
| +7% | +$3.54K |
|
1928
Accuray
ARAY
$28.4M
| $41.9K | ﹤0.01% |
16,951
+1,334
| +9% | +$3.57K |
|
|
GRTS
1929
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $41.6K | ﹤0.01% |
16,197
+1,672
| +12% | +$4.08K |
|
|
ME
1930
DELISTED
23andMe Holding Co
ME
| $41.5K | ﹤0.01% |
3,900
+385
| +11% | +$4.95K |
|
|
AGEN
1931
Agenus
AGEN
$249M
| $39.7K | ﹤0.01% |
3,422
+269
| +9% | +$3.57K |
|
1932
Amylyx Pharmaceuticals
AMLX
$2.05B
| $39.4K | ﹤0.01% |
13,874
+1,153
| +9% | +$15.1K |
|
1933
iHeartMedia
IHRT
$535M
| $39K | ﹤0.01% |
18,664
+1,470
| +9% | +$3.46K |
|
|
KYNB
1934
Kyntra Bio
KYNB
$28.5M
| $39K | ﹤0.01% |
664
+53
| +9% | +$2.28K |
|
|
PSTX
1935
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $39K | ﹤0.01% |
12,210
+960
| +9% | +$3.2K |
|
|
FRGE
1936
DELISTED
Forge Global Holdings
FRGE
| $38.1K | ﹤0.01% |
1,316
+103
| +8% | +$3.22K |
|
1937
Omeros
OMER
$709M
| $37.7K | ﹤0.01% |
10,938
+880
| +9% | +$3.35K |
|
1938
SES AI
SES
$186M
| $37.7K | ﹤0.01% |
22,434
+1,766
| +9% | +$2.65K |
|
1939
Taysha Gene Therapies
TSHA
$1.59B
| $37.6K | ﹤0.01% |
13,103
+1,157
| +10% | +$2.41K |
|
|
KG
1940
Kestrel Group
KG
$71.3M
| $36.7K | ﹤0.01% |
816
+65
| +9% | +$2.22K |
|
1941
American Well
AMWL
$181M
| $36.7K | ﹤0.01% |
2,263
+202
| +10% | +$4.33K |
|
1942
Destination XL Group
DXLG
$34.7M
| $36.4K | ﹤0.01% |
+10,101
| New | +$39.6K |
|
|
PHLT
1943
DELISTED
Performant Healthcare Inc
PHLT
| $36.2K | ﹤0.01% |
12,311
+1,172
| +11% | +$3.35K |
|
1944
Quantum-Si Incorporated
QSI
$168M
| $36K | ﹤0.01% |
18,280
+1,440
| +9% | +$2.52K |
|
1945
Organogenesis Holdings
ORGO
$308M
| $35.8K | ﹤0.01% |
12,620
+995
| +9% | +$3.38K |
|
|
ONL
1946
Orion Office REIT
ONL
$148M
| $35.5K | ﹤0.01% |
+10,119
| New | +$45.4K |
|
1947
Lineage Cell Therapeutics
LCTX
$257M
| $35.3K | ﹤0.01% |
23,841
+1,877
| +9% | +$2.13K |
|
1948
Nerdy
NRDY
$107M
| $33.9K | ﹤0.01% |
11,649
+1,294
| +12% | +$3.99K |
|
1949
Microvast
MVST
$267M
| $33.1K | ﹤0.01% |
39,518
+3,933
| +11% | +$3.51K |
|
1950
Gevo
GEVO
$397M
| $32.7K | ﹤0.01% |
42,554
+3,847
| +10% | +$3.35K |
|
Similar funds
ProShare Advisors's Q1 2024 Portfolio in Review
As of Q1 2024, ProShare Advisors held 2,051 positions worth $37.6B, up 15% from $32.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
ProShare Advisors deployed $2.25B of net new capital in Q1 2024, opening 98 new positions and adding to 1,226 existing holdings. Its largest new stake was SS&C Technologies: 123,548 shares worth $7.95M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Industrials and Consumer Staples.
On the sell side, the largest reduction was Walgreens Boots Alliance, an estimated $163M trimmed.
- ProShare Advisors's largest Q1 2024 buy was SS&C Technologies: 123,548 shares worth $7.95M.
- ProShare Advisors added most to Microsoft in Q1 2024, an estimated $202M increase.
- ProShare Advisors's biggest Q1 2024 reduction was Walgreens Boots Alliance, cutting an estimated $163M.
- ProShare Advisors fully exited Splunk Inc in Q1 2024, selling an estimated $20.4M.
- ProShare Advisors's ten largest holdings make up 24% of its $37.6B portfolio in Q1 2024.
- ProShare Advisors opened 98 new positions and closed 47 in Q1 2024.
- ProShare Advisors's portfolio value rose 15% quarter-over-quarter to $37.6B.
Based on ProShare Advisors's 13F filing for Q1 2024, filed 8 May 2024.